GlaxoSmithKline’s difficult year continued today as shares tumbled on a warning that it no longer expects to improve a key measure of earnings.

GlaxoSmithKline and Swiss rival Novartis are to create a consumer healthcare powerhouse as part of a string of deals in the pharmaceuticals sector today.

Drugs giant GlaxoSmithKline has launched an investigation into allegations of corruption in Iraq just months after becoming embroiled in a major bribery scandal in China.

Drugs giant GlaxoSmith-Kline will stop paying for doctors to attend medical conferences and scrap some sales targets as it seeks to mend its reputation in the wake of a damaging scandal over multimillion-pound bribery claims in China.

Drugs giant GlaxoSmithKline will stop paying for doctors to attend medical conferences and scrap some sales targets as it seeks to mend its reputation in the wake of a damaging scandal over multimillion-euro bribery claims in China.

Drugs giant GlaxoSmithKline has revealed a corruption probe in China sent sales of pharmaceuticals and vaccines in the country plummeting 61%.

Soft drinks brands Lucozade and Ribena could be bought by Japan’s Suntory Beverage & Food within days in a deal worth more than £1bn.

Another 18 GlaxoSmithKline employees have been detained by Chinese authorities as a major criminal investigation into alleged corruption widens.

Another 18 GlaxoSmithKline employees have been detained by Chinese authorities as a major criminal investigation into alleged corruption widens.

The head of drugs giant GlaxoSmithKline has sought to blame a handful of senior managers for corruption allegations it is facing in China and said the company itself had been a victim of their actions.

GlaxoSmithKline chief executive Andrew Witty will detail what action the drugmaker is taking in response to allegations of bribery against it in China when he presents quarterly results on Wednesday, according to sources.

GlaxoSmith Kline, a major manufacturer of anti-diabetes drugs, has decided to sell its Lucozade and Ribena brands — a move that coincides with the release of a major study that shows drinking one can of fizzy drinks a day increases the likelihood of contracting diabetes by 20%.

GlaxoSmithKline has put iconic drinks Lucozade and Ribena under review as it looks for the “best ways to ensure their continued growth”.

Drugs giant GlaxoSmithKline today called on European governments to halt aggressive price cuts on medicines or suffer “unintended consequences”.

GlaxoSmithKline warned that sales in 2012 would be flat as pressure on drug prices intensifies in Europe, due to government austerity measures aimed at curbing healthcare bills.

Drugs firm GlaxoSmithKline will pay $3bn (€2.4bn) in fines after admitting to the largest healthcare fraud in US history.

The head of Europe’s drug industry has written to EU leaders ahead of their summit this week, seeking major concessions to help keep supplies of medicines flowing to crisis-hit states.

Pharmaceutical giant GlaxoSmithKline said its $2.6bn (€1.98bn) bid for long-time partner Human Genome Sciences was “full and fair” and it was the only obvious owner for the US biotechnology firm.

Drugs giant GlaxoSmithKline said it was disappointed that an offer worth £1.6bn (€1.94bn) for US-based Human Genome Sciences (HGS) has been rejected.

GlaxoSmithKline today agreed to one of the largest fines ever levied on a pharmaceuticals firm to settle a trio of long-running disputes with the US government.

Drugs giant GlaxoSmithKline is to “rev up” its research and manufacturing operations through a tie-up with Formula 1 team McLaren.

DRUGMAKERS GlaxoSmithKline and Eli Lilly posted weaker than expected quarterly revenue, continuing an industry theme and underscoring challenges from price cuts and a lack of new products.

Drugs giant GlaxoSmithKline today reported a £147m (€165.5m) hit after writing off stocks of its controversial diabetes drug Avandia.

PHARMACEUTICAL groups, like food stocks, are seen as good defensive investments when the global economy is sinking and stock markets are in rapid decline.

Drug maker GlaxoSmithKline today said sales of its Lucozade drink slumped 12% as it announced lower quarterly profits amid slumping US performance.

Drugs giant GlaxoSmithKline today reported a 14% slide in third quarter profits and said it was losing close to £3bn (€3.81bn) in annual sales as competition from cheaper generic rivals heats up.

The new head of GlaxoSmithKline today said the drug giant must change to survive the growing threat of generic competition for its leading products.

One of the world’s largest pharmaceutical firms GlaxoSmithKline today announced a replacement for chief executive Jean-Paul Garnier.

ONE of the world’s largest pharmaceutical companies confirmed it is to invest €250 million in a Co Cork plant, creating a further 150 jobs.